Search results
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
Morningstar· 6 days agoOcugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced ...
Clarifeye Total Eye Care expands to Shenandoah, offering personalized eye care services
Community Impact· 3 days agoResidents in Shenandoah and southern Montgomery County have a new option for personalized eye care...
Santa J. Ono, University of Michigan President, Joins USJF Board
The Longview News-Journal· 1 day agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga· 2 days agoThe data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint ...
Obituaries in Topeka, KS | Topeka Capital-Journal
The Topeka Capital-Journal· 6 days agoMargery Adeana McClacherty at the age of 96 peacefully passed away on April 27, 2024. Margery was born on September 10, 1927, in Bellingham, Washington; daughter of the late Guy William and ...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 5 days agoEquities researchers at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 7 days agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
REGENXBIO (NASDAQ:RGNX) Downgraded by StockNews.com to “Sell”
ETF DAILY NEWS· 15 hours agoStockNews.com cut shares of REGENXBIO (NASDAQ:RGNX – Free Report) from a hold rating to a sell rating in a report published on Tuesday. Chardan Capital reaffirmed a buy rating and set a $52.00 ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 6 days agoFirst quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 24% to $3.08 billion versus first
Santa J. Ono, University of Michigan President, Joins USJF Board
Wisconsin State Journal· 1 day agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...
